Likmez Suspension
NDC Package 81033-066-20

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Likmez (metronidazole oral) suspension is metronidazole is an antibiotic that is used to treat a wide variety of infections. This formulation utilizes a suspension delivery system. Marketed by Kesin Pharma Corporation, this product is identified by NDC 81033-066 and is authorized under FDA application NDA216755.

Identification & Billing

NDC Package Code
81033-066-20
Package Description
200 mL in 1 BOTTLE
Product Code
81033-066
11-Digit Billing Format
81033006620
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Likmez
Non-Proprietary Name
Metronidazole Oral
Substance Name
Metronidazole
Dosage Form
Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
METRONIDAZOLE 100 mg/mL
Pharmacologic Class
Usage Information
Metronidazole is an antibiotic that is used to treat a wide variety of infections. It works by stopping the growth of certain bacteria and parasites. This antibiotic treats only certain bacterial and parasitic infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Metronidazole may also be used with other medications to treat certain stomach/intestinal ulcers caused by a bacteria (H. pylori).

Regulatory & Marketing

Labeler Name
Kesin Pharma Corporation
Product Type
Human Prescription Drug
FDA Application #
NDA216755
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-13-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 81033-066-20 identifies a specific commercial package of 200 ml in 1 bottle of Likmez, a human prescription drug labeled by Kesin Pharma Corporation. This suspension is formulated for oral use and contains metronidazole as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kesin Pharma Corporation on October 13, 2023. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Metronidazole is an antibiotic that is used to treat a wide variety of infections. It works by stopping the growth of certain bacteria and parasites. This antibiotic treats only certain bacterial and parasitic infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Metronidazole may also be used with other medications to treat certain stomach/intestinal ulcers caused by a bacteria (H. pylori).

How is this Kesin Pharma Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 81033006620. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
81033-066-20
11-Digit CMS (5-4-2)
81033-0066-20

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.